Resveratrol transport and metabolism by human intestinal Caco-2 cells.
about
Novel nutraceutic therapies for the treatment of metabolic syndromeFatty acid ethyl esters induce intestinal epithelial barrier dysfunction via a reactive oxygen species-dependent mechanism in a three-dimensional cell culture model.Resveratrol and cancer: focus on in vivo evidence.Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity.Bioavailability challenges associated with development of anti-cancer phenolics.Comparision of piceid and resveratrol in antioxidation and antiproliferation activities in vitro.Colorectal cancer: chemopreventive role of curcumin and resveratrol.Resveratrol: challenges in translation to the clinic--a critical discussion.Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity.Anti-proliferative and gene expression actions of resveratrol in breast cancer cells in vitroPleiotropic mechanisms facilitated by resveratrol and its metabolites.Resveratrol: French paradox revisited.First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.The biological responses to resveratrol and other polyphenols from alcoholic beverages.Bioavailability of resveratrol.Role of membrane dynamics processes and exogenous molecules in cellular resveratrol uptake: consequences in bioavailability and activities.Phenolic compounds: their journey after intake.Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2).Influence of glucuronidation and reduction modifications of resveratrol on its biological activities.Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells.Resveratrol reverses the Warburg effect by targeting the pyruvate dehydrogenase complex in colon cancer cellsAbsorption, Conjugation and Efflux of the Flavonoids, Kaempferol and Galangin, Using the Intestinal CACO-2/TC7 Cell Model.Multidrug resistance proteins restrain the intestinal absorption of trans-resveratrol in rats.Ethanol extract of peanut sprout induces Nrf2 activation and expression of antioxidant and detoxifying enzymes in human dermal fibroblasts: implication for its protection against UVB-irradiated oxidative stress.Microbial metabolism. Part 14. Isolation and bioactivity evaluation of microbial metabolites of resveratrol.Resveratrol and inflammatory bowel disease: the evidence so far.Red wine consumption not associated with reduced risk of colorectal cancer.Novel bioassay system for evaluating anti-oxidative activities of food items: use of basolateral media from differentiated Caco-2 cells.Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1.Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms.Development of a Solid Dispersion System for Improving the Oral Bioavailability of Resveratrol in Rats.New Water-Soluble Carbamate Ester Derivatives of ResveratrolPhenolic Compounds Characteristic of the Mediterranean Diet in Mitigating Microglia-Mediated Neuroinflammation
P2860
Q26748558-C6EA1982-9A70-4A4E-8107-6FB1EA7FD14AQ31113913-48C69A25-217B-4EDA-A6F9-C419279B8270Q33578943-A7608A22-0637-4D3E-A4A1-2032E74910D8Q34054119-4435CC7B-B8B3-4272-8E65-3C0898064EE5Q34057398-10A09BA5-0B24-459B-BD2B-5C003E0DAF7AQ34559483-2164B9E1-92BF-472B-AD3D-0F39229E0C2AQ34624184-3C1DB110-7E98-4708-A7B2-F02F4DDC5256Q34673721-0B7DE7E4-1424-435F-8004-2A4F7EA4A965Q35145256-92A81CD5-5C69-40F4-BE77-DA8918752A65Q35149578-1A86BC18-AF17-46C7-9B4E-FC62FB5480B8Q35692517-1CDC8C08-C98E-494E-800A-601B0E7D8883Q36099455-D2F4A913-7A26-4A7F-989E-F8208C068EB5Q36132293-3F8EC795-3DC4-4CC5-9DEB-CF2ACDFBAE31Q37436072-A2A553D8-B769-4B31-BEB6-A5D05B012525Q37831925-1B813719-309C-407B-8C4A-41FD3FFECAECQ37885882-3154FE40-E7C4-4FF8-8B6B-F61E8ACBF55FQ38171254-14ACEBE2-2472-4514-94BD-0A62BB6719D1Q39026925-88A49665-BE36-4CD7-9662-38F12ED5D613Q39147997-D47844D6-0B08-4AB7-BCCA-4B99A4ADEFF0Q39411151-1EE0F5F0-7942-4A4A-BDF8-5BE1122D2685Q41192215-2FCF4B66-F845-40C7-90B6-1B9CD1F63B6FQ41995134-0E8BDECD-92DB-472E-8251-4E10CC6A9859Q43188243-65310D04-17FE-44DA-BD1D-4B5CA8E99D65Q45116218-FE236404-6486-4C0F-B535-49ADB23FD79BQ46142801-AB87C915-D291-4348-8E94-2A11935C51F5Q46250847-7CBD4D8A-59E6-4115-9EB6-43B550DCA1FCQ46617346-981F22C1-DBBF-49D4-91F4-E096A28718FEQ46813150-EEAF545A-AC94-46DA-90B3-B2A834A374E9Q46897796-EF5CE6AE-3FD5-494E-863C-750F9F87B6A5Q50734428-AABE5249-8572-45D3-8576-DC959FE1DC72Q54632986-305354C1-5B29-4E9F-8E7C-7E38A9E4EC15Q57974104-3B96EB03-4DE2-4A6B-BEF9-69778AA7645CQ58572097-9D2A8D8D-D5CF-4AF6-AF5A-965A7E28F9AF
P2860
Resveratrol transport and metabolism by human intestinal Caco-2 cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Resveratrol transport and metabolism by human intestinal Caco-2 cells.
@en
type
label
Resveratrol transport and metabolism by human intestinal Caco-2 cells.
@en
prefLabel
Resveratrol transport and metabolism by human intestinal Caco-2 cells.
@en
P2093
P2860
P356
P1476
Resveratrol transport and metabolism by human intestinal Caco-2 cells.
@en
P2093
Mark I Kaldas
Thomas Walle
U Kristina Walle
P2860
P304
P356
10.1211/002235702612
P577
2003-03-01T00:00:00Z